P53 pathway

1 study on P53 pathway mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

2026-04-24 PubMed

FOXO4-DRI peptide reverses age-related kidney damage and dysfunction by inducing apoptosis in senescent cells

This review consolidates evidence that targeted senolytics like **FOXO4-DRI** are a viable strategy for mitigating age-related kidney decline. For peptide users and researchers, this highlights a mechanism beyond trad…

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.